Related Experiment Video
Updated: Dec 21, 2025

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
Published on: January 10, 2019
Optical coherence tomography and multiple sclerosis: Update on clinical application and role in clinical trials
Jeffrey Lambe1, Shiv Saidha1, Robert A Bermel2
1Department of Neurology, Johns Hopkins Hospital, Baltimore, MD, USA.
Abstract:
Optical coherence tomography (OCT) has emerged as a fast, non-invasive, inexpensive, high-resolution imaging technique in multiple sclerosis (MS). Retinal layer quantification by OCT facilitates a 'window' into not only local retinal pathology but also global neurodegenerative processes, recognised to be the principal substrates of disability accumulation in MS. While OCT measures in MS have been demonstrated to reflect visual function, inflammatory activity outside of the visual pathways, disability measures including the prediction of disability progression, whole brain atrophy, and the differential neuroprotective effects of disease-modifying therapies, debate continues regarding the clinical utility of OCT in everyday practice. This review presents an overview of the evidence supporting OCT, with particular focus on its application in the MS clinic. We will also discuss the role of OCT in MS clinical trials to develop novel neuroprotective and potential remyelinating therapies.
Related Concept Videos
Imaging Studies III: Computed Tomography
Clinical Trials: Overview
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Imaging Studies IV: Magnetic Resonance Imaging
Computed Tomography
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
Clinical Trials
There are four phases in a clinical trial. A phase one...

